UA112974C2 - Нікотиновмісна композиція (варіанти) - Google Patents

Нікотиновмісна композиція (варіанти)

Info

Publication number
UA112974C2
UA112974C2 UAA201304861A UAA201304861A UA112974C2 UA 112974 C2 UA112974 C2 UA 112974C2 UA A201304861 A UAA201304861 A UA A201304861A UA A201304861 A UAA201304861 A UA A201304861A UA 112974 C2 UA112974 C2 UA 112974C2
Authority
UA
Ukraine
Prior art keywords
nicotine
options
dosage form
nicotine composition
polacrylexic
Prior art date
Application number
UAA201304861A
Other languages
English (en)
Inventor
Бхарат Правінчандра Мента
Райєн Дхірубхай Шах
Маной Кантілал Пател
Пармешвар Б. Банг
Original Assignee
Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид filed Critical Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид
Publication of UA112974C2 publication Critical patent/UA112974C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Abstract

Розкрито нікотиновмісну тверду пероральну трансмукозальну лікарську форму, що містить терапевтично ефективну кількість нікотину полакрилексу, моногідрат лимонної кислоти, сахарозу та рідку глюкозу, де вміст цукрового сиропу перевищує 95 мас. %. Лікарська форма більш прийнятно перебуває у формі пастилки.
UAA201304861A 2010-09-16 2010-01-12 Нікотиновмісна композиція (варіанти) UA112974C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2564MU2010 2010-09-16
PCT/IN2010/000775 WO2012035541A1 (en) 2010-09-16 2010-12-01 Nicotine containing formulation

Publications (1)

Publication Number Publication Date
UA112974C2 true UA112974C2 (uk) 2016-11-25

Family

ID=45831078

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201304861A UA112974C2 (uk) 2010-09-16 2010-01-12 Нікотиновмісна композиція (варіанти)

Country Status (10)

Country Link
US (1) US9180124B2 (uk)
EP (1) EP2496083A4 (uk)
AU (1) AU2010360967B2 (uk)
BR (1) BR112012031102B8 (uk)
CA (1) CA2782734C (uk)
EA (1) EA025779B1 (uk)
MX (1) MX339470B (uk)
UA (1) UA112974C2 (uk)
WO (1) WO2012035541A1 (uk)
ZA (1) ZA201206589B (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
ES2471665B1 (es) * 2012-12-21 2015-03-12 Farmalider Sa Producto sustitutivo del tabaco
WO2015136124A1 (es) * 2014-03-11 2015-09-17 Farmalider, S.A. Producto sustitutivo del tabaco
CN111226941B (zh) * 2020-02-15 2021-08-20 浙江大学 一种防治作物害虫的植物源杀虫剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317576D0 (en) 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5110605A (en) 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
PL187242B1 (pl) 1996-05-13 2004-06-30 Novartis Consumer Health Sa Policzkowy układ dostarczający
AR033444A1 (es) 2001-03-26 2003-12-17 Smithkline Beecham Corp Forma solida de dosificacion util para la administracion oral de un compuesto activo de nicotina, a traves de la mucosa y uso de un compuesto activo de nicotina para prepararla
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US20040107971A1 (en) * 2002-09-17 2004-06-10 Abhijit De Gum based chewing product and process for preparing the same
DK1803444T3 (en) * 2002-12-20 2019-02-25 Niconovum Ab PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC)
DE102005058569B4 (de) 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
ITTV20060039A1 (it) 2006-03-14 2007-09-15 Nice Spa Sistema di controllo per uno o piu' azionamenti.
US20090214442A1 (en) 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
US20100124560A1 (en) 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof

Also Published As

Publication number Publication date
BR112012031102B8 (pt) 2021-05-25
US20120244104A1 (en) 2012-09-27
BR112012031102B1 (pt) 2021-05-18
US9180124B2 (en) 2015-11-10
CA2782734C (en) 2018-03-27
MX339470B (es) 2016-05-27
ZA201206589B (en) 2014-02-26
EP2496083A1 (en) 2012-09-12
CA2782734A1 (en) 2012-03-22
WO2012035541A1 (en) 2012-03-22
EA201390394A1 (ru) 2013-07-30
BR112012031102A2 (pt) 2015-09-22
MX2012012973A (es) 2013-03-05
EA025779B1 (ru) 2017-01-30
EP2496083A4 (en) 2013-05-01
AU2010360967A1 (en) 2012-07-05
AU2010360967B2 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
UA112974C2 (uk) Нікотиновмісна композиція (варіанти)
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2012092594A3 (en) Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
WO2014207770A8 (en) A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same
NZ623495A (en) Oral formulations of cytidine analogs and methods of use thereof
MY139913A (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
WO2007125545A3 (en) Transmucosal composition
WO2012079092A3 (en) Testosterone undecanoate compositions
MX2008000087A (es) Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5.
WO2010039762A3 (en) Pharmaceutical compositions comprising boronic acid compounds
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
WO2011146876A3 (en) Oral transmucosal administration of sufentanil
MX342986B (es) Formulaciones para el tratamiento de las afecciones de las vias aereas superiores.
PE20080994A1 (es) Jarabes antihistaminicos, estables al almacenamiento sin azucar
MX2015008837A (es) Composiciones parenterales estables de dnj.
WO2008087323A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
WO2006100595A3 (en) Chewing gum compositions of varenicline
EA201170108A1 (ru) Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки
MX346039B (es) Solucion farmaceutica bebible de telmisartan.
MX2015008068A (es) Unidad solida con alto contenido en fexofenadina y su procedimiento de preparacion.
PL2252263T3 (pl) Postać galenowa do podawania tryptanów poprzez błonę śluzową policzka
CN102342896A (zh) 一种生物酶漱口水
WO2010135505A3 (en) Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
WO2008105533A1 (ja) カプシノイド化合物含有アディポネクチン分泌促進剤